Pulmonary arterial hypertension Trials in Brussels, Belgium
Conditions / Pulmonary arterial hypertension / Brussels, Belgium
Clinical trials for Pulmonary arterial hypertension investigate a range of treatment strategies and patient populations.
26 total trials for this combination
Showing top 10 of 26 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ENROLLING_BY_INVITATION | PHASE3 |
| NCT01106014 | Selexipag (ACT-293987) in Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |
| NCT04273945 | Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01112306 | ACT-293987 in Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |
| NCT04084678 | A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH | TERMINATED | PHASE3 |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT01027949 | An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |
| NCT04796337 | A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004/A011-12) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05036135 | A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) | TERMINATED | PHASE2/PHASE3 |
| NCT04576988 | A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR) | COMPLETED | PHASE3 |